De novo mTOR inhibitor-based immunosuppression in ABO-incompatible kidney trans-plantation.

Koch M, Wiech T, Marget M, Peine S, Thude H, Achilles EG, Fischer L, Lehnhardt A, Thaiss F, Nashan B.

Clin Transplant. 2015 Nov;29(11):1021-8.

The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy.

Engel O, Soave A, Peine S, Kluth LA, Schmid M, Shariat SF, Dahlem R, Fisch M, Rink M.

World J Urol. 2015 Nov;33(11):1769-76.

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182,
miR-376a and miR-429 in ovarian cancer patients.

Meng X, Joosse SA, Müller V, Trillsch F, Milde-Langosch K, Mahner S, Geffken M, Pantel K, Schwarzenbach H.

Br J Cancer. 2015 Nov 3;113(9):1358-66.

Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephro-ureterectomy for Upper Tract Urothelial Carcinoma.

Rink M, Soave A, Dahlem R, Aziz
A, Al-Sayed F, Peine S, Engel O, Kluth LA, Stenzl A, Burger M, Shariat
SF, Fisch M, Fritsche HM, Gakis G.

Clin Genitourin Cancer. 2015 Oct 20.

Decreased serum concentrations of sphingosine-1-phosphate in sepsis.

Winkler MS, Nierhaus A, Holzmann M, Mudersbach E, Bauer A, Robbe L, Zahrte C, Geffken M, Peine S, Schwedhelm E, Daum G, Kluge S, Zoellner C.

Crit Care. 2015 Oct 26;19(1):372.

Donor choice in haploidentical stem cell transplantation: fetal microchimerism is associated with better outcome in pediatric leukemia patients.

Kruchen A, Stahl T, Gieseke F, Binder TM, Özcan Z, Meisel R, Kreyenberg H, Bader P, Gruhn B, Greil J, Pfeiffer M, Döring M, Handgretinger R, Fehse B, Müller I.

Bone Marrow Transplant. 2015 Oct;50(10):1367-70

Long-term Clinical Relevance of De Novo Donor-Specific Antibodies After Pediatric Liver
Transplantation.

Grabhorn E, Binder TM, Obrecht D, Brinkert F, Lehnhardt A, Herden U, Peine S, Nashan B, Ganschow R, Briem-Richter A.

Transplantation. 2015 Sep;99(9):1876-81.

Role of the Fyn -93A>G polymorphism (rs706895) in acute rejection after liver transplan-tation.

Thude H, Kramer K, Peine S, Sterneck M, Nashan B, Koch M.

Hum Immunol. 2015 Sep;76(9):657-62.

Relevance of chronic hepatitis E in liver transplant recipients: a real-life setting.

Galante A, Pischke S, Polywka S, Luetgehethmann M, Suneetha PV, Gisa A, HillerJ, Dienes HP, Nashan B, Lohse AW, Sterneck M.

Transpl Infect Dis. 2015 Aug;17(4):617-22.

Impaired DNase1-mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies.

Jiménez-Alcázar M, Napirei M, Panda R, Köhler EC, Kremer Hovinga JA, Mannherz HG, Peine S, Renné T, Lämmle B, Fuchs TA.

J Thromb Haemost. 2015 May;13(5):732-42.

Development of a novel IGRA assay to test T cell responsiveness to HBV antigens in whole
blood of chronic Hepatitis B patients.

Dammermann W, Bentzien F, Stiel EM, Kühne C, Ullrich S, Schulze Zur Wiesch J, Lüth S.

J Transl Med. 2015 May 13;13:157.

Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in
Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects.

Wellbrock J, Latuske E, Köhler J, Wagner K, Stamm H, Vettorazzi E, Vohwinkel G, Klokow M, Uibeleisen R, Ehm P, Riecken K, Loges S, Thol F, Schubert C, Amling M, Jücker M, Bokemeyer C, Heuser M, Krauter J, Fiedler W.

Clin Cancer Res. 2015 May 15;21(10):2388-98.

High B-cell activating factor is not associated with worse 3-year graft outcome in
blood group-incompatible kidney transplantation with rituximab induction.

Lehnhardt AM, Strecker M, Eiermann T, Marget M, Thaiss F, Nashan B, Koch M.

Clin Transplant. 2015 Apr;29(4):359-64.

A rare ancestral HLA-DRB1(∗)15:01̃DQB1(∗)02:01 haplotype and its reversion in the same Western European family.

Binder TM, Kelsch R, Wikner JM, Aly L, Brendel C, Alster I, Kühnl P, Finckh U, Eiermann TH.

Hum Immunol. 2015 Mar;76(2-3):124-8.

Syndrome hémolytique et urémique.

Schmidtko J, Rohrer F, Peine S.

Rev Med Suisse. 2015 Feb 25;11(463):523.

Tetramer enrichment reveals the presence of phenotypically diverse hepatitis C virus-specific CD8+ T cells in chronic infection.

Nitschke K, Flecken T, Schmidt J, Gostick E, Marget M, Neumann-Haefelin C, Blum HE, Price DA, Thimme R.

J Virol. 2015 Jan;89(1):25-34.